# Gildan Activewear Inc.: financial statements, quarterly

GIL · NYSE · CIK 1061894 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Jan 3

Pages: [Overview](/companies/gil.md) · [Financials](/companies/gil/financials.md) · [Filings](/companies/gil/filings.md) · [Insiders](/companies/gil/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/gil/financials.md?period=annual).

## Balance sheet

| Line item | Unit | period not labelled (2016-01-03) | period not labelled (2017-01-01) | FY2017 (2017-12-31) | FY2018 (2018-12-30) | FY2019 (2019-12-29) | FY2020 (2021-01-03) | FY2021 (2022-01-02) | FY2022 (2023-01-01) | FY2023 (2023-12-31) | FY2024 (2024-12-29) | FY2025 (2025-12-28) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.1](/filings/0001061894-18-000006.md) | [0.0](/filings/0001061894-19-000008.md) | [0.1](/filings/0001061894-20-000009.md) | [0.0](/filings/0001061894-21-000006.md) | [0.1](/filings/0001061894-22-000005.md) | [0.5](/filings/0001061894-23-000007.md) | [0.2](/filings/0001061894-24-000010.md) | [0.2](/filings/0001061894-25-000007.md) | [0.1](/filings/0001061894-25-000007.md) | [0.1](/filings/0001061894-26-000006.md) | [0.3](/filings/0001061894-26-000006.md) |
| Current assets | $bn | not reported | [1.3](/filings/0001061894-18-000006.md) | [1.3](/filings/0001061894-19-000008.md) | [1.4](/filings/0001061894-20-000009.md) | [1.5](/filings/0001061894-21-000006.md) | [1.5](/filings/0001061894-22-000005.md) | [1.4](/filings/0001061894-23-000007.md) | [1.7](/filings/0001061894-24-000010.md) | [1.7](/filings/0001061894-25-000007.md) | [1.9](/filings/0001061894-26-000006.md) | [4.7](/filings/0001061894-26-000006.md) |
| Total assets | $bn | not reported | [3.0](/filings/0001061894-18-000006.md) | [3.0](/filings/0001061894-19-000008.md) | [3.0](/filings/0001061894-20-000009.md) | [3.2](/filings/0001061894-21-000006.md) | [3.0](/filings/0001061894-22-000005.md) | [3.1](/filings/0001061894-23-000007.md) | [3.4](/filings/0001061894-24-000010.md) | [3.5](/filings/0001061894-25-000007.md) | [3.7](/filings/0001061894-26-000006.md) | [10.5](/filings/0001061894-26-000006.md) |
| Current liabilities | $bn | not reported | [0.2](/filings/0001061894-18-000006.md) | [0.3](/filings/0001061894-19-000008.md) | [0.3](/filings/0001061894-20-000009.md) | [0.4](/filings/0001061894-21-000006.md) | [0.4](/filings/0001061894-22-000005.md) | [0.5](/filings/0001061894-23-000007.md) | [0.6](/filings/0001061894-24-000010.md) | [0.7](/filings/0001061894-25-000007.md) | [0.8](/filings/0001061894-26-000006.md) | [2.2](/filings/0001061894-26-000006.md) |
| Total liabilities | $bn | not reported | [0.9](/filings/0001061894-18-000006.md) | [0.9](/filings/0001061894-19-000008.md) | [1.1](/filings/0001061894-20-000009.md) | [1.4](/filings/0001061894-21-000006.md) | [1.5](/filings/0001061894-22-000005.md) | [1.2](/filings/0001061894-23-000007.md) | [1.6](/filings/0001061894-24-000010.md) | [1.6](/filings/0001061894-25-000007.md) | [2.3](/filings/0001061894-26-000006.md) | [6.9](/filings/0001061894-26-000006.md) |
| Shareholders' equity | $bn | [2.2](/filings/0001061894-18-000006.md) | [2.1](/filings/0001061894-19-000008.md) | [2.1](/filings/0001061894-20-000009.md) | [1.9](/filings/0001061894-21-000006.md) | [1.8](/filings/0001061894-22-000005.md) | [1.6](/filings/0001061894-23-000007.md) | [1.9](/filings/0001061894-24-000010.md) | [1.9](/filings/0001061894-25-000007.md) | [2.0](/filings/0001061894-26-000006.md) | [1.5](/filings/0001061894-26-000006.md) | [3.6](/filings/0001061894-26-000006.md) |

- Cash and equivalents: ifrs-full:CashAndCashEquivalents
- Current assets: ifrs-full:CurrentAssets
- Total assets: ifrs-full:Assets
- Current liabilities: ifrs-full:CurrentLiabilities
- Total liabilities: ifrs-full:Liabilities
- Shareholders' equity: ifrs-full:EquityAttributableToOwnersOfParent

Shares outstanding: 185,152,443 at 2025-12-28, from the cover of the [40-F filed 2026-02-26](/filings/0001061894-26-000006.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:32 ET. No prices; not investment advice.